Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciano Quaranta

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Glaucoma|August 11, 2018
The Glaucoma Italian Pediatric Study (GIPSy): 3-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
Advances in Therapy|July 3, 2025
Relationships Among Glaucoma, Cardiovascular Diseases, and MortalityLuciano Quaranta, Alessia A Galbussera, Mauro Tettamanti, et al.
Expert Opinion on Drug Safety|September 21, 2020
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability reviewAnastasios G Konstas, Leopold Schmetterer, Vital P Costa, et al.
Advances in Therapy|December 4, 2016
24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost MonotherapyAnastasios-Georgios Konstas, Konstadinos G Boboridis, Paraskevas Kapis, et al.
Advances in Therapy|April 25, 2020
Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost MonotherapyAnastasios-Georgios Konstas, Konstadinos G Boboridis, Paraskevas Kapis, et al.
Advances in Therapy|October 21, 2018
Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and TreatmentAnastasios G Konstas, Malik Y Kahook, Makoto Araie, et al.
European Journal of Ophthalmology|March 16, 2021
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centersRoberto dell'Omo, Mariaelena Filippelli, Gianni Virgili, et al.
Acta Ophthalmologica|December 8, 2015
Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational studyIrene Floriani, Luciano Quaranta, Eliana Rulli, et al.
Ophthalmic Research|December 20, 2011
Risk factors associated with progression in exfoliative glaucoma patientsGábor Holló, Luciano Quaranta, Barbara Cvenkel, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 28, 2011
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in EuropeGábor Holló, Ulrich Thelen, Miguel A Teus, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Glaucoma|August 11, 2018
The Glaucoma Italian Pediatric Study (GIPSy): 3-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
Advances in Therapy|July 3, 2025
Relationships Among Glaucoma, Cardiovascular Diseases, and MortalityLuciano Quaranta, Alessia A Galbussera, Mauro Tettamanti, et al.
Expert Opinion on Drug Safety|September 21, 2020
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability reviewAnastasios G Konstas, Leopold Schmetterer, Vital P Costa, et al.
Advances in Therapy|December 4, 2016
24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost MonotherapyAnastasios-Georgios Konstas, Konstadinos G Boboridis, Paraskevas Kapis, et al.
Advances in Therapy|April 25, 2020
Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost MonotherapyAnastasios-Georgios Konstas, Konstadinos G Boboridis, Paraskevas Kapis, et al.
Advances in Therapy|October 21, 2018
Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and TreatmentAnastasios G Konstas, Malik Y Kahook, Makoto Araie, et al.
European Journal of Ophthalmology|March 16, 2021
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centersRoberto dell'Omo, Mariaelena Filippelli, Gianni Virgili, et al.
Acta Ophthalmologica|December 8, 2015
Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational studyIrene Floriani, Luciano Quaranta, Eliana Rulli, et al.
Ophthalmic Research|December 20, 2011
Risk factors associated with progression in exfoliative glaucoma patientsGábor Holló, Luciano Quaranta, Barbara Cvenkel, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 28, 2011
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in EuropeGábor Holló, Ulrich Thelen, Miguel A Teus, et al.
Pageof 11